GefitinibAcquired resistance in non-small cell lung cancer: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1660卷 / 1期

关键词：

D O I：

10.1007/s40278-017-33129-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：164 / 164

相关论文

共 50 条

[21] Alectinib/crizotinibDevelopment of resistance in non-small cell lung cancer: case report
[J]. Reactions Weekly, 2016, 1616 (1) : 15 - 15
[22] Carboplatin/paclitaxelAcquired drug resistance and transformation of non-small cell lung cancer to small cell lung cancer: case report
[J]. Reactions Weekly, 2020, 1804 (1) : 88 - 88
[23] CrizotinibDevelopment of resistance during treatment for non-small cell lung cancer: case report
[J]. Reactions Weekly, 2017, 1666 (1) : 91 - 91
[24] Erlotinib/gefitinib/osimertinibDevelopment of resistance in non-small cell lung cancer: case report
[J]. Reactions Weekly, 2021, 1850 (1) : 131 - 131
[25] Gefitinib/osimertinibAcquired resistance in advanced non-small cell lung cancer: case report
[J]. Reactions Weekly, 2021, 1863 (1) : 165 - 165
[26] GefitinibDevelopment of drug resistance in non-small cell lung cancer adenocarcinoma: case report
[J]. Reactions Weekly, 2017, 1668 (1) : 192 - 192
[27] AtezolizumabHyperprogression of non-small cell lung cancer: case report
[J]. Reactions Weekly, 2020, 1789 (1) : 52 - 52
[28] Case report: Hypereosinophilia in non-small cell lung cancer
Kwon, Hyunwoo
Li, Mingjia
Sheldon, Jesse D.
Jones, Nicholas
Crestani, Nicolas Gallastegui
Li, Zihai
Owen, Dwight H.
[J]. CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2024, 13
[29] PembrolizumabHyperprogression of non-small cell lung cancer : case report
[J]. Reactions Weekly, 2024, 2020 (1) : 379 - 379
[30] PembrolizumabHyperprogression of non-small cell lung cancer: case report
[J]. Reactions Weekly, 2020, 1828 (1) : 411 - 411

← 1 2 3 4 5 →